Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 267

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1A
Chunk 267
---
 from the date the accompanying financial
statements are issued.

The accompanying financial statements have been prepared on a going
concern basis, which contemplates the realization of assets and the satisfaction of obligations in the normal course of business, and
do not include any adjustments to the amount and classification of assets and liabilities that may be necessary should we be unable to
continue as a going concern.

53

Contractual Obligations

The following table summarizes our contractual obligations as of December
31, 2024:

    Payments Due By Period 

    Total  
    Less than 
    1 year  
    1-3 years  
    4-5 years  
    More than
    5 Years 
  
    Principal obligations on the debt arrangements 
    $150,000  
    $-  
    $3,621  
    $6,799  
    $139,580 
  
    Interest obligations on the debt arrangements 
     104,797  
     8,772  
     13,923  
     10,746  
     71,356 
  
    Accounts payable and accrued expenses 
     1,007,618  
     1,007,618  
     -  
     -  
     - 
  
    Total 
    $1,262,415  
    $1,016,390  
    $17,544  
    $17,545  
    $210,936 

Amounts related to contingent milestone payments
are not considered contractual obligations as they are contingent on the achievement of certain milestones. These contingent milestones
may or may not be achieved. We have not included any of these amounts in the table above as we cannot estimate or predict when, or if,
these amounts will become due.

Cash Flows

    Year Ended December 31,  

    2024  
    2023  
    $ Change  
    % Change 
  
    Net Cash (Used In) Provided By : 

    Operating Activities 
    $(5,648,088) 
    $(4,542,910) 
    $(1,105,178) 
     24.33%
  
    Investing Activities 
     (1,889,114) 
     (115,888) 
     (1,773,226) 
     1,530.12 
  
    Financing Activities 
     7